Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Acrocephalosyndactylia × brivanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1 Endometrial Adenocarcinoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Advanced Hepatocellular Carcinoma (HCC) 1 Acrocephalosyndactylia 1

Interventions

pemigatinib 5 derazantinib 2 pembrolizumab 1 brivanib 1 atezolizumab 1 Irinotecan 1 INCB 54828-101 1 Gemcitabine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01367275 2020-09-03

Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

M.D. Anderson Cancer Center

Phase 2 Terminated

8 enrolled 5 charts

Gastrointestinal

Acrocephalosyndactylia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡